BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33079640
Number of visits today
1530
Number of downloads
16281849
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Javitt DC, Kantrowitz JT. The glutamate/N-methyl-d-aspartate receptor (NMDAR) model of schizophrenia at 35: On the path from syndrome to disease. Schizophrenia Research 2022. [DOI: 10.1016/j.schres.2022.01.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Nakamura T, Dinh TH, Asai M, Matsumoto J, Nishimaru H, Setogawa T, Honda S, Yamada H, Mihara T, Nishijo H. Suppressive effects of ketamine on auditory steady-state responses in intact, awake macaques: A non-human primate model of schizophrenia. Brain Res Bull 2023;193:84-94. [PMID: 36539101 DOI: 10.1016/j.brainresbull.2022.12.006] [Reference Citation Analysis]
2 Javitt DC. Cognitive Impairment Associated with Schizophrenia: From Pathophysiology to Treatment. Annu Rev Pharmacol Toxicol 2023;63:119-41. [PMID: 36151052 DOI: 10.1146/annurev-pharmtox-051921-093250] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Sehatpour P, Iosifescu DV, De Baun HM, Shope C, Mayer MR, Gangwisch J, Dias E, Sobeih T, Choo T, Wall MM, Medalia A, Saperstein AM, Kegeles LS, Girgis RR, Carlson M, Kantrowitz JT. Dose dependent augmentation of neuroplasticity-based auditory learning in schizophrenia: a double-blind, placebo-controlled, randomized, target engagement clinical trial of the N-methyl-D-aspartate-type glutamate receptor (NMDAR) agonist d-serine. Biological Psychiatry 2023. [DOI: 10.1016/j.biopsych.2023.01.015] [Reference Citation Analysis]
4 Deckler E, Ferland M, Brazis S, Mayer MR, Carlson M, Kantrowitz JT. Challenges and Strategies for the Recruitment of Patients With Schizophrenia in a Research Setting. Int J Neuropsychopharmacol 2022;25:924-32. [PMID: 36037521 DOI: 10.1093/ijnp/pyac058] [Reference Citation Analysis]
5 Tandon R, Keshavan M, Nasrallah H. Reinventing schizophrenia. Updating the construct. Schizophr Res 2022:S0920-9964(22)00093-7. [PMID: 35241314 DOI: 10.1016/j.schres.2022.02.024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345